Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
102.36
+1.06 (1.05%)
At close: Jun 23, 2025, 4:00 PM
102.47
+0.11 (0.11%)
After-hours: Jun 23, 2025, 7:55 PM EDT
Boston Scientific Stock Forecast
Stock Price Forecast
The 22 analysts that cover Boston Scientific stock have a consensus rating of "Strong Buy" and an average price target of $112.86, which forecasts a 10.26% increase in the stock price over the next year. The lowest target is $78 and the highest is $130.
Price Target: $112.86 (+10.26%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Boston Scientific stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 11 | 12 | 12 | 10 |
| Buy | 9 | 10 | 10 | 10 | 10 | 11 |
| Hold | 3 | 2 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 23 | 23 | 23 | 23 | 23 | 22 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Initiates $118 | Buy | Initiates | $118 | +15.28% | Jun 16, 2025 |
| Needham | Needham | Strong Buy Reiterates $115 | Strong Buy | Reiterates | $115 | +12.35% | May 28, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $119 → $125 | Strong Buy | Maintains | $119 → $125 | +22.12% | May 22, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $120 → $125 | Buy | Maintains | $120 → $125 | +22.12% | May 16, 2025 |
| Barclays | Barclays | Buy Maintains $118 → $125 | Buy | Maintains | $118 → $125 | +22.12% | Apr 25, 2025 |
Financial Forecast
Revenue This Year
19.69B
from 16.75B
Increased by 17.56%
Revenue Next Year
21.80B
from 19.69B
Increased by 10.75%
EPS This Year
2.94
from 1.25
Increased by 135.46%
EPS Next Year
3.32
from 2.94
Increased by 12.93%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 20.8B | 23.1B | 25.8B | ||
| Avg | 19.7B | 21.8B | 24.0B | ||
| Low | 18.6B | 20.9B | 22.8B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 24.1% | 17.2% | 18.4% | ||
| Avg | 17.6% | 10.8% | 10.1% | ||
| Low | 11.3% | 5.9% | 4.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.13 | 3.69 | 4.15 | ||
| Avg | 2.94 | 3.32 | 3.75 | ||
| Low | 2.82 | 3.11 | 3.44 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 150.3% | 25.2% | 24.8% | ||
| Avg | 135.5% | 12.9% | 12.7% | ||
| Low | 125.8% | 5.6% | 3.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.